Guanylyl cyclase C–induced immunotherapeutic responses opposing tumor metastases without autoimmunity

AE Snook, BJ Stafford, P Li, G Tan… - JNCI: Journal of the …, 2008 - academic.oup.com
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

[引用][C] Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

AE SNOOK, BJ STAFFORD… - Journal of the …, 2008 - pascal-francis.inist.fr
Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases
Without Autoimmunity CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

AE Snook, BJ Stafford, P Li, G Tan, L Huang… - J Natl Cancer …, 2008 - research.jefferson.edu
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity.

AE Snook, BJ Stafford, P Li, G Tan… - JNCI: Journal of the …, 2008 - search.ebscohost.com
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

[HTML][HTML] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

AE Snook, BJ Stafford, P Li, G Tan… - JNCI Journal of the …, 2008 - ncbi.nlm.nih.gov
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

AE Snook, BJ Stafford, P Li, G Tan, L Huang, R Birbe… - J Natl Cancer Inst, 2008 - Citeseer
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity

AE Snook, BJ Stafford, P Li, G Tan… - Journal of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

AE Snook, BJ Stafford, P Li, G Tan, L Huang… - J Natl Cancer …, 2008 - academia.edu
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity

AE Snook, BJ Stafford, P Li, G Tan, L Huang… - J Natl Cancer …, 2008 - researchgate.net
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.

AE Snook, BJ Stafford, P Li, G Tan, L Huang… - Journal of the …, 2008 - europepmc.org
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …